Insiders GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 19:35:01 06/03/2026 +03			5-day change	1st Jan Change
2,038.00 ^GBX	-1.83%		-7.41%	+11.70%

03-05	Illumina, Inc. and Nashville Biosciences, LLC Announce New Proteomics Data Offering and Expansion of Alliance for Genomic Discovery Dataset	CI
03-05	GSK outgoing CEO Emma Walmsley's 2025 total remuneration was 15.7 mln pounds vs 10.6 mln pounds in 2024 - annual report	RE

Insiders

02-20	GSK non-executive director buys nearly GBP75,000 in shares	AN
02-17	Berenberg Says GSK 'Best Performer' in Pharmaceutical Sector; Price Target Up	MT
02-13	NatWest results ahead of forecasts, ups dividend 51%	AN
02-13	Sanofi's new CEO needs to fix drug pipeline and navigate Trump	RE
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-12	Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant	RE
02-06	GSK Chair Jonathan Symonds buys GBP53,000 in shares	AN
02-04	GSK optimistic for 2026 after fourth-quarter results beat forecast	AN
02-04	GSK's Specialty Medicines Drive Solid Results	DJ
02-04	GSK forecasts slower sales growth in 2026	RE
02-04	GSK eyes sharper, faster drug development as new CEO signals growth plan	RE
02-02	GSK cutting jobs in UK and US as part of ongoing R&D changes	AN
01-30	Immunocore Holdings plc Announces Executive Changes	CI
01-28	Omass Therapeutics Announces Board Changes	CI
01-09	Croda International plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026	CI
01-09	Praxis Precision Medicines, Inc. Announces Management and Committees Changes	CI
01-08	GSK plc Appoints Luke Victor Miels as Director, Effective January 1, 2026	CI
01-05	GSK PLC Announces Termination of Director Appointment of Emma Natasha Walmsley, Effective December 31, 2025	CI
12-30	GSK PLC outlook improves amid merger speculation
12-24	Vor Biopharma Inc Announces Board Appointments, Effective December 18, 2025	CI
11-24	Heidelberg Pharma AG Announces Chief Executive Officer Changes, Effective 24 November 2025	CI
11-10	Haleon plc Announces Board Changes	CI
11-10	Haleon Names Vindi Banga as Chair	DJ
11-10	Diageo Assures 'Good Progress' in CEO Hunt as Concern Grows Among Investors	MT
11-08	Diageo has considered external candidates for CEO role, FT reports	RE